impact factorComing 2018

Frontiers reaches 6.4 on Journal Impact Factors

Erratum ARTICLE

Front. Oncol., 18 May 2018 | https://doi.org/10.3389/fonc.2018.00172

Erratum: Melanoma Unknown Primary Brain Metastasis Treatment With ECHO-7 Oncolytic Virus Rigvir: A Case Report

  • Frontiers Media SA, Lausanne, Switzerland

An erratum on

Melanoma Unknown Primary Brain Metastasis Treatment With ECHO-7 Oncolytic Virus Rigvir: A Case Report
by Proboka G, Tilgase A, Isajevs S, Rasa A, Alberts P. Front Oncol (2018) 8:43. doi: 10.3389/fonc.2018.00043

In the original article, we neglected to include the patient consent statement.

Patient Consent Statement

Written consent to publication was obtained from the patient.

The Production office apologize for this error and state that this does not change the scientific conclusions of the article in any way.

The original article was updated.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Keywords: melanoma brain metastasis, melanoma unknown primary, blood–brain barrier, oncolytic virus, ECHO-7 virus, intranasal, Rigvir®

Citation: Frontiers Production Office (2018) Erratum: Melanoma Unknown Primary Brain Metastasis Treatment With ECHO-7 Oncolytic Virus Rigvir: A Case Report. Front. Oncol. 8:172. doi: 10.3389/fonc.2018.00172

Received: 02 May 2018; Accepted: 02 May 2018;
Published: 18 May 2018

Approved by:

Oncology Editorial Office, Frontiers, Switzerland

Copyright: © 2018 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Production Office, production.office@frontiersin.org